Usa covid-19 pandemic vaccine Usa

Experts say COVID-19-affected drug market rebounding

Reading now: 615
www.cidrap.umn.edu

As the first surge of the COVID-19 pandemic hit in the spring, the headlines began heralding the need for more robust and secure supply chains and warning about critical drug shortages.

At that point, there was only so much that pharmaceutical companies could do, but a recent analysis by the Healthcare Distribution Alliance, the national organization representing primary pharmaceutical distributors, provided a positive perspective on the industry's performance during the pandemic's first 90 days.The report, titled "The First 90 Days: US Biopharmaceutical Finished Goods Supply Chain Response to COVID-19," was prepared by Deloitte and highlighted the shift of drug distributors' operations owing to COVID-19.

Read more on cidrap.umn.edu
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA